Your browser doesn't support javascript.
loading
Seegene Anyplex II assays detect HPV consistently using DNA extracts from different extraction methods.
Balgovind, Prisha; Murray, Gerald; Machalek, Dorothy A; Garland, Suzanne M; Azzato, Francesco; Hinaut, Jee A; Danielewski, Jennifer; Molano, Monica; Haqshenas, Gholamreza.
Affiliation
  • Balgovind P; Centre for Women's Infectious Diseases, The Royal Women's Hospital, Melbourne, Vic 3052, Australia.
  • Murray G; Murdoch Children's Research Institute, Melbourne, Vic 3052, Australia.
  • Machalek DA; Centre for Women's Infectious Diseases, The Royal Women's Hospital, Melbourne, Vic 3052, Australia.
  • Garland SM; Murdoch Children's Research Institute, Melbourne, Vic 3052, Australia.
  • Azzato F; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Vic 3052, Australia.
  • Hinaut JA; Centre for Women's Infectious Diseases, The Royal Women's Hospital, Melbourne, Vic 3052, Australia.
  • Danielewski J; The Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
  • Molano M; Centre for Women's Infectious Diseases, The Royal Women's Hospital, Melbourne, Vic 3052, Australia.
  • Haqshenas G; Murdoch Children's Research Institute, Melbourne, Vic 3052, Australia.
Lett Appl Microbiol ; 77(5)2024 May 03.
Article in En | MEDLINE | ID: mdl-38688871
ABSTRACT
The efficiency of PCR-based diagnostic assays can be impacted by the quality of DNA template, and anal samples can be particularly problematic due to the presence of faecal contaminants. Here, we compared the Quick-DNA Viral Kit (Zymo, Zymo Research, CA) and MagNA Pure 96 DNA and Viral NA Small Volume Kit (MP96, Roche) for use of the Seegene Anyplex II HPV28 assay (Anyplex28, Seegene) with anal samples. A total of 94 anal samples extracted using the MP96 and Zymo kits were tested via the Anyplex28, which detects high-risk human papillomavirus (HR-HPV, Panel A) and low-risk (LR-HPV, Panel B) HPV types. Testing the HR-HPV types (Panel A), 86 (91.5%) MP96 and 84 (89.4%) Zymo samples were deemed assessable. Overall agreement between the two methods was 87/94 (92.6%, 95% CI 85.3-97.0) with the Kappa value of 0.678 (0.5-0.9). Of the 87 assessable samples, 50 (57.5%) were concordant, 34 (39.1%) partially concordant, and 10 (11.5%)discordant. In conclusion, the Anyplex28 produces comparable HPV genotyping results when using DNA extracts from either of these two methods.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Papillomaviridae / DNA, Viral / Papillomavirus Infections Limits: Humans Language: En Journal: Lett Appl Microbiol Journal subject: MICROBIOLOGIA Year: 2024 Type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Papillomaviridae / DNA, Viral / Papillomavirus Infections Limits: Humans Language: En Journal: Lett Appl Microbiol Journal subject: MICROBIOLOGIA Year: 2024 Type: Article Affiliation country: Australia